Accuray Incorporated announced that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery hypofractionated radiotherapy delivered with the TomoTherapy® System is superior...
Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers, announced that the Company will advance...
ASGARD Partners & Co. announced that its portfolio company, Angstrom Technology ("Angstrom" or the "Company"), an industry leader in cleanroom design and production, has...
Arkuda Therapeutics, a biotechnology company applying novel insights at the intersection of lysosomal and microglial biology to develop medicines to change the trajectory of...
Kinetic River Corp., a leader in development of advanced flow cytometry technology, announced the successful completion of a Phase II Small Business Innovation Research...
